This mouse study demonstrated that the gut microbiota is necessary and sufficient for the anti-seizure effects of the ketogenic diet. Specifically, *Akkermansia* and *Parabacteroides* species were enriched by the ketogenic diet and, when administered together, conferred seizure protection even in mice fed a control diet. Metabolomic analysis revealed that this effect is associated with altered levels of gamma-glutamylated amino acids and changes in hippocampal GABA/glutamate ratios.

None identified.

This is a well-designed study with compelling evidence of a gut-brain connection in seizure control. The research uses multiple approaches, including antibiotic treatments, germ-free mice, and gnotobiotic colonization to establish the necessity and sufficiency of the gut microbiota. The study also explores the potential mechanism of action through metabolomics and bacterial cross-feeding experiments. The findings have significant implications for epilepsy treatment, though more research is needed to validate these results in humans and to understand the specific neurological mechanisms.